Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Nat Rev Cancer. 2012 Apr 5;12(5):363-8. doi: 10.1038/nrc3235.

    Cancer imaging by optical coherence tomography: preclinical progress and clinical potential.

    Source

    Wellman Center for Photomedicine and Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA. vakoc.benjamin@mgh.harvard.edu

    Abstract

    The past decade has seen dramatic technological advances in the field of optical coherence tomography (OCT) imaging. These advances have driven commercialization and clinical adoption in ophthalmology, cardiology and gastrointestinal cancer screening. Recently, an array of OCT-based imaging tools that have been developed for preclinical intravital cancer imaging applications has yielded exciting new capabilities to probe and to monitor cancer progression and response in vivo. Here, we review these results, forecast the future of OCT for preclinical cancer imaging and discuss its exciting potential to translate to the clinic as a tool for monitoring cancer therapy.

    PMID:
    22475930
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3560400
    Free PMC Article

    Images from this publication.See all images (2)Free text

    Figure 1
    Figure 2

      Supplemental Content

      Icon for Nature Publishing Group Icon for PubMed Central
      Write to the Help Desk